Gene · 5169
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The impact of digital transformation on the total factor productivity of heavily polluting enterprises. | Sci Rep | 2023 | 37076699 | PubTator, text mining | PubMed |
| The association between eosinophils (CD16+ eosinophils), basophils (CD203+ basophils), and CD23 B lymphocytes in patients with atopic dermatitis on dupilumab therapy: pilot study. | Dermatol Ther (Heidelb) | 2023 | 37071375 | PubTator, text mining | PubMed |
| The evolution and structure of snake venom phosphodiesterase (svPDE) highlight its importance in venom actions. | Elife | 2023 | 37067034 | PubTator, text mining | PubMed |
| Analysis of human lung mast cells by single cell RNA sequencing. | Front Immunol | 2023 | 37063885 | PubTator, text mining | PubMed |
| Identification of cancer-associated fibroblasts subtypes in prostate cancer. | Front Immunol | 2023 | 37033924 | PubTator, text mining | PubMed |
| CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis. | Front Immunol | 2023 | 37025992 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models. | Immunohorizons | 2023 | 37000496 | PubTator, text mining | PubMed |
| Emerging of a new CD3+CD31HCD184+ tang cell phenothype in Sjögren's syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells. | Front Immunol | 2023 | 36999025 | PubTator, text mining | PubMed |
| Correspondence to "Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study". | Allergy | 2023 | 36995969 | PubTator, text mining | PubMed |
| A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy. | Pharmaceutics | 2023 | 36986774 | PubTator, text mining | PubMed |
| The Allergenic Activity of Blo t 2, a Blomia tropicalis IgE-Binding Molecule. | Int J Mol Sci | 2023 | 36982614 | PubTator, text mining | PubMed |
| Advancing Luciferase-Based Antibody Immunoassays to Next-Generation Mix and Read Testing. | Biosensors (Basel) | 2023 | 36979515 | PubTator, text mining | PubMed |
| Nanobodies Selectively Binding to the Idiotype of a Dengue Virus Neutralizing Antibody Do Not Necessarily Mimic the Viral Epitope. | Biomolecules | 2023 | 36979486 | PubTator, text mining | PubMed |
| Biomarkers associated with persistence and severity of IgE-mediated food allergies: a systematic review. | J Pediatr (Rio J) | 2023 | 36977497 | PubTator, text mining | PubMed |
| Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response. | Clin Transl Allergy | 2023 | 36973953 | PubTator, text mining | PubMed |
| Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression. | Cancer Gene Ther | 2023 | 36973425 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 | 36973268 | PubTator, text mining | PubMed |
| Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy. | Leuk Res Rep | 2023 | 36968263 | PubTator, text mining | PubMed |
| A Qualitative Study on the Humanistic Care Needs of Patients with Stroke and Their Families. | J Multidiscip Healthc | 2023 | 36959865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5169/papers?page=11